Ravi Viswanathan, 10% Owner at AVEO PHARMACEUTICALS INC (AVEO), bought 275 shares at $2.15 ($591) on 2018-05-30, disclosed to the SEC on 2018-05-30.
Open-market purchase of $591 AVEO by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| AVEO | BUY | 2018-07-20 | $491K | — | Filing → |
| AVEO | BUY | 2018-06-28 | $404K | — | Filing → |
| AVEO | BUY | 2018-05-21 | $897K | — | Filing → |